Efficacy and Safety of Danirixin (GSK1325756) Co-administered With Standard-of-Care Antiviral (Oseltamivir): A Phase 2b, Global, Randomized Study of Adults Hospitalized With Influenza

Lignende værker

• Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Tolerability, and Clinical Effect of Danirixin in Adults With Acute, Uncomplicated Influenza
  af: Roberts, Grace, et al.
  Udgivet: (2019)
• The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756) − a selective CXCR2 antagonist − in healthy adult subjects
  af: Miller, Bruce E., et al.
  Udgivet: (2015)
• The pharmacokinetics of conventional and bioenhanced tablet formulations of danirixin (GSK1325756) following oral administration in healthy, elderly, human volunteers
  af: Miller, Bruce E., et al.
  Udgivet: (2014)
• Pharmacokinetics of Orally Administered Oseltamivir in Healthy Obese and Nonobese Thai Subjects
  af: Jittamala, Podjanee, et al.
  Udgivet: (2014)
• A randomized, crossover study to evaluate the pharmacokinetics of amantadine and oseltamivir administered alone and in combination.
  af: Dennis Morrison, et al.
  Udgivet: (2007-12-01)